European stock futures head south
Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at markets.research@thomsonreuters.com
EUROPEAN STOCK FUTURES HEAD SOUTH
European equity markets look set to open the final day of a choppy week in the red, as investors attempt to digest what Trump and his policies might mean for global stocks.
Euro STOXX 50 futures STXEc1 are down around 0.7%, with the index so far having gained about 0.6% for the week. Futures on Germany's DAX .GDAXI, Britain's FTSE .FTSE and France's CAC 40 are down between 0.4%-0.6%.
Trump, late on Thursday, announced Robert F. Kennedy Jr., who has previously spread misinformation on vaccines, to lead the Department of Health and Human Services in his new administration.
European vaccine makers - such as GSK GSK.L, Biontech 22UAy.DE and Sanofi SASY.PA - could be in focus at the open.
In other corporate news, Italy's top insurer Generali GASI.MI posted 9-month profit above estimates, despite a 930 million hit from natural disasters.
On the M&A front, German drug developer Evotec EVTG.DE has received an 11 euros per share offer from Halozyme Therapeutics HALO.O, valuing the company at about 2 billion euros.
(Samuel Indyk)
*****
FRIDAY'S OTHER LIVE MARKETS POSTS:
CHINESE CONSUMERS SPEND MORE, JUST NOT ON PROPERTY CLICK HERE
China's mixed October data keeps stimulus calls alive https://reut.rs/3YPXD6v
Related Assets
Latest News
Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.
All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.
Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.
